Sirolimus News and Research

RSS
New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

New clinical trial examines potential role of drug combination therapy to eliminate LAM cells

UC scientists take different approach to investigating how influenza spreads through the lungs

UC scientists take different approach to investigating how influenza spreads through the lungs

OrbusNeich launches new Dual Therapy Stent for active vessel healing

OrbusNeich launches new Dual Therapy Stent for active vessel healing

Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

Study of new polymer-free DFS indicates non-inferior in-stent late lumen loss at nine-months

TCT 2016 features first report investigations on novel bioresorbable stents

TCT 2016 features first report investigations on novel bioresorbable stents

ATS releases new clinical practice guidelines for diagnosis, management of LAM

ATS releases new clinical practice guidelines for diagnosis, management of LAM

PCI with polymer-free BA9 drug-coated stent better than bare metal stent in ACS patients

PCI with polymer-free BA9 drug-coated stent better than bare metal stent in ACS patients

Rare disease day focuses on new approach to finding treatment

Rare disease day focuses on new approach to finding treatment

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Novartis announces FDA approval of Afinitor for progressive, nonfunctional neuroendocrine tumors of GI

Sirolimus chemoprevention supported in organ transplant recipients

Sirolimus chemoprevention supported in organ transplant recipients

Patients with treatment-resistant autoimmune blood conditions may benefit from sirolimus

Patients with treatment-resistant autoimmune blood conditions may benefit from sirolimus

FDA awards research grants to boost product development for patients with rare diseases

FDA awards research grants to boost product development for patients with rare diseases

PRESTIGE study suggests novel target to prevent stent thrombosis

PRESTIGE study suggests novel target to prevent stent thrombosis

Steroid-refractory chronic GVHD trial results ‘overestimate’ treatment efficacy

Steroid-refractory chronic GVHD trial results ‘overestimate’ treatment efficacy

Mayo Clinic heart transplant surgeons present findings from three clinical studies at ISHLT 2015

Mayo Clinic heart transplant surgeons present findings from three clinical studies at ISHLT 2015

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

STENTYS signs agreement to acquire assets of Cappella Peel Away

STENTYS signs agreement to acquire assets of Cappella Peel Away

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Docs who treat patients with severe LAM face agonizing treatment decision

Docs who treat patients with severe LAM face agonizing treatment decision